Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:07 PM
Ignite Modification Date:
2025-12-24 @ 9:07 PM
NCT ID:
NCT03029104
Eligibility Criteria:
Inclusion Criteria:
* A diagnosis of at least one of the following conditions:
1. Keratoconus
2. Forme fruste keratoconus
3. Post-LASIK ectasia
4. Pellucid marginal degeneration
5. Forme fruste pellucid marginal degeneration
6. Diurnal fluctuation post-radial keratotomy
7. Terrien's marginal degeneration
Exclusion Criteria:
1. Corneal thickness \< 375 microns measured by ultrasound or Pentacam.
2. Contraindications or hypersensitivities to any study medications or their components.
3. Pregnancy or breastfeeding.
4. Any history of herpes simplex corneal disease in an eye to be treated.
5. Nystagmus or any other condition that would, in the judgement of the investigator, prevent a steady gaze during the treatment.
6. Inability to cooperate with diagnostic tests.
7. Enrollment in another ophthalmic clinical trial.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
8 Years
Study:
NCT03029104
Study Brief:
Protocol Section:
NCT03029104